ARTICLE | Clinical News
Remicade infliximab: Marketed
May 10, 1999 7:00 AM UTC
CNTO published in The New England Journal of Medicine previously reported results of its 94-patient Phase III trial of Remicade in Crohn's disease patients with fistulas (see BioCentury, Nov. 10, 1997...